academic article

• Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study..  Acta psychiatrica Scandinavica.  :-. 2015
• Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report..  Acta psychiatrica Scandinavica.  130:354-363. 2014
• The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders..  The American journal of psychiatry.  170:1249-1262. 2013
• Predominant recurrence polarity among 928 adult international bipolar I disorder patients..  Acta psychiatrica Scandinavica.  125:293-302. 2012
• Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients..  World psychiatry : official journal of the World Psychiatric Association (WPA).  11:40-46. 2012
• Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project..  Journal of affective disorders.  136:1-8. 2012
• Factors modifying drug and placebo responses in randomized trials for bipolar mania..  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP).  14:863-875. 2011
• 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery..  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.  21:287-293. 2011
• McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients..  The Journal of clinical psychiatry.  72:183-193. 2011
• Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study..  Journal of affective disorders.  127:50-57. 2010
• Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)..  European psychiatry : the journal of the Association of European Psychiatrists.  25:338-344. 2010
• Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis..  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP).  13:813-832. 2010
• Bipolar depression: overview and commentary..  Harvard review of psychiatry.  18:143-157. 2010
• Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania..  The Journal of clinical psychiatry.  71:255-261. 2010
• Onset-age of bipolar disorders at six international sites..  Journal of affective disorders.  121:143-146. 2010
• Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients..  Journal of affective disorders.  119:22-27. 2009
• Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)..  Journal of affective disorders.  118:118-123. 2009
• Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico..  Journal of clinical psychopharmacology.  29:358-361. 2009
• The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders..  Bipolar disorders.  11:453-473. 2009
• Antipsychotic agents in the treatment of bipolar mania..  Bipolar disorders.  11 Suppl 2:45-54. 2009
• McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients..  The Journal of clinical psychiatry.  70:458-466. 2009
• Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study..  The Journal of clinical psychiatry.  69:1776-1789. 2008
• Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania..  Journal of affective disorders.  110:126-134. 2008
• Stability and treatment outcome of distinct classes of mania..  European psychiatry : the journal of the Association of European Psychiatrists.  23:360-367. 2008
• Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study..  Journal of affective disorders.  106:63-72. 2008
• Effect of comorbid anxiety on treatment response in bipolar depression..  Journal of affective disorders.  104:137-146. 2007
• Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study..  Actas españolas de psiquiatría.  35:315-322. 2007
• Outcomes for Latin American versus White patients suffering from acute mania in a randomized, double-blind trial comparing olanzapine and haloperidol..  Journal of clinical psychopharmacology.  27:126-134. 2007
• Functional impairment in patients with mania: baseline results of the EMBLEM study..  Bipolar disorders.  9:45-52. 2007
• Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes..  Current medical research and opinion.  22:961-966. 2006
• Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data..  The Journal of clinical psychiatry.  65:1420-1428. 2004
• A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania..  Archives of general psychiatry.  60:1218-1226. 2003
• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression..  Archives of general psychiatry.  60:1079-1088. 2003
• Olanzapine versus placebo in acute mania: treatment responses in subgroups..  Journal of clinical psychopharmacology.  23:370-376. 2003
• Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling..  Journal of affective disorders.  73:155-161. 2003
• Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder..  Journal of clinical psychopharmacology.  21:469-473. 2001